Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
343.262362693
InChI
InChI=1S/C21H33N3O/c1-5-24(6-2)14-10-8-7-9-12-22-20-16-18(25-4)15-19-17(3)11-13-23-21(19)20/h11,13,15-16,22H,5-10,12,14H2,1-4H3
InChI Key
InChIKey=RVAKDGYPIVSYEU-UHFFFAOYSA-N
IUPAC Name
diethyl({6-[(6-methoxy-4-methylquinolin-8-yl)amino]hexyl})amine
Traditional IUPAC Name
diethyl({6-[(6-methoxy-4-methylquinolin-8-yl)amino]hexyl})amine
SMILES
CCN(CC)CCCCCCNC1=CC(OC)=CC2=C(C)C=CN=C12
pKa (strongest acidic)
17.89
pKa (Strongest Basic)
10.33
Refractivity
107.91 m3·mol-1
Cơ Chế Tác Dụng :
Sitamaquine (WR-6026) is an orally active 8-aminoquinoline analog in development by the Walter Reed Army Institute, in collaboration with GlaxoSmithKline (formerly SmithKline Beecham), for the potential treatment of visceral leishmaniasis.
The mechanism of plasmodicidal action of sitamaquine is not completely understood. Like other quinoline derivatives, it is thought to inhibit heme polymerase activity. This results in accumulation of free heme, which is toxic to the parasites.
Chỉ Định :
Investigated for use/treatment in infectious and parasitic disease (unspecified).